1. Home
  2. BSII vs NPCE Comparison

BSII vs NPCE Comparison

Compare BSII & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSII
  • NPCE
  • Stock Information
  • Founded
  • BSII 2024
  • NPCE 1997
  • Country
  • BSII Hong Kong
  • NPCE United States
  • Employees
  • BSII N/A
  • NPCE N/A
  • Industry
  • BSII
  • NPCE Medical Specialities
  • Sector
  • BSII
  • NPCE Health Care
  • Exchange
  • BSII Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • BSII 188.8M
  • NPCE 217.5M
  • IPO Year
  • BSII 2024
  • NPCE 2021
  • Fundamental
  • Price
  • BSII $9.86
  • NPCE $9.00
  • Analyst Decision
  • BSII
  • NPCE Buy
  • Analyst Count
  • BSII 0
  • NPCE 7
  • Target Price
  • BSII N/A
  • NPCE $15.71
  • AVG Volume (30 Days)
  • BSII 9.6K
  • NPCE 119.2K
  • Earning Date
  • BSII 01-01-0001
  • NPCE 11-12-2024
  • Dividend Yield
  • BSII N/A
  • NPCE N/A
  • EPS Growth
  • BSII N/A
  • NPCE N/A
  • EPS
  • BSII N/A
  • NPCE N/A
  • Revenue
  • BSII N/A
  • NPCE $76,452,000.00
  • Revenue This Year
  • BSII N/A
  • NPCE $20.21
  • Revenue Next Year
  • BSII N/A
  • NPCE $15.04
  • P/E Ratio
  • BSII N/A
  • NPCE N/A
  • Revenue Growth
  • BSII N/A
  • NPCE 27.00
  • 52 Week Low
  • BSII $9.86
  • NPCE $5.45
  • 52 Week High
  • BSII $10.09
  • NPCE $18.15
  • Technical
  • Relative Strength Index (RSI)
  • BSII N/A
  • NPCE 64.58
  • Support Level
  • BSII N/A
  • NPCE $8.46
  • Resistance Level
  • BSII N/A
  • NPCE $10.42
  • Average True Range (ATR)
  • BSII 0.00
  • NPCE 0.90
  • MACD
  • BSII 0.00
  • NPCE 0.18
  • Stochastic Oscillator
  • BSII 0.00
  • NPCE 67.65

About BSII Black Spade Acquisition II Co Class A Ordinary Share

Black Spade Acquisition II Co is a blank check company.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Share on Social Networks: